Funding Opportunities

Current Funding OpportunitiesRSS

Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)

Source: NIH Office of Extramural Research
Innovative and Early-Stage Development of Emerging Technologies in Biospecimen Science (R21)

Source: NIH Office of Extramural Research
Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)

Source: NIH Office of Extramural Research
Early-Stage Innovative Technology Development for Cancer Research (R21)

Source: NIH Office of Extramural Research
Transformative Research

Source: NIH Office of Extramural Research

Past Funding OpportunitiesRSS

Data Center for the Clinical Proteomic Technologies for Cancer

Source: Federal Business Opportunities
New Technology for Proteomics and Glycomics (STTR [R41/R42])

Source: NIH Office of Extramural Research
Clinical Proteomic Technologies for Cancer Initiative: Proteome Characterization Centers (U24)

Source: NIH Office of Extramural Research

Launch Antibody Portal »

The Antibody Portal serves as a public resource of monoclonal antibodies made available by the NCI for the scientific community to support protein/peptide measurement and analysis efforts.